Commercialization

Our group believes strongly in making new technologies available to others and one excellent way to achieve this is through commercialization efforts. In many instances this occurs through partnership with a company and applying for SBIR grants, on which the lab performs part of the research as a subcontract.

Several projects in the lab at are various stages in the commercialization process:
  • The ELIXYS 3-reactor automated radiosynthesizer and unit-operation based programming interface has been commercialized and is being sold by Sofie Biosciences, Inc. Click here to view the product webpage.

  • EWOD-chip based radiosynthesizer: currently undergoing commercial development with Sofie Biosciences, Inc. (under the name PHENYX)